TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Troubled Roswell Park Cancer Institute Bets On Recruitment To Regain Its Luster. January 19, 2001
TCL Archive Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads July 16, 1976
